"Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch.
Luxiq Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Luxiq (betamethasone valerate) is a topical corticosteroid used to treat skin conditions of the scalp such as psoriasis or seborrhea (dandruff). Side effects of Luxiq include mild burning, stinging or itching at the site of application.
Luxiq is supplied in 150 gram, 100 gram, and 50 gram doses. Avoid getting this medication in your eyes, mouth, and nose, or on your lips. If it does get into any of these areas, wash with water. Luxiq may interact with other corticosteroids. Tell your doctor all medications you use. If you are pregnant, talk with your doctor about risks and benefits. Consult your doctor before breastfeeding.
Our Luxiq (betamethasone valerate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Luxiq in Detail - Patient Information: Side Effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using this medication and call your doctor at once if you have any of these signs that you may be absorbing betamethasone topical through your skin or gums:
- blurred vision, or seeing halos around lights;
- uneven heartbeats;
- mood changes;
- sleep problems (insomnia);
- weight gain, puffiness in your face; or
- feeling tired.
Less serious side effects may include:
- skin redness, burning, itching, or peeling;
- thinning of your skin; or
- blistering skin; or
- stretch marks.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Luxiq (Betamethasone Valerate Foam)
What is Patient Information Overview?
A concise overview of the drug for the patient or caregiver from First DataBank.
Luxiq Overview - Patient Information: Side Effects
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Tell your doctor immediately if any of these unlikely but serious side effects occur: stretch marks, skin thinning/discoloration, acne, extreme/unwanted hair growth, "hair bumps" (folliculitis).
Rarely, it is possible this medication will be absorbed from the skin into the bloodstream. This can lead to side effects of too much corticosteroid. These side effects are more likely in children, and in people who use this medication for a long time or over large areas of the skin. Tell your doctor right away if any of the following side effects occur: unusual/extreme tiredness, weight loss, headache, swelling ankles/feet, increased thirst/urination, vision problems.
A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Luxiq (Betamethasone Valerate Foam)
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Luxiq FDA Prescribing Information: Side Effects
The most frequent adverse event was burning/itching/stinging at the application site; the incidence and severity of this event were as follows:
|Incidence and severity of burning/itching/stinging|
|Product||Total incidence||Maximum severity|
|34 (54%)||28 (44%)||5 (8%)||1 (2%)|
|Betamethasone valerate lotion
|33 (52%)||26(41%)||6 (10%)||1 (2%)|
|24 (75%)||13(41%)||7 (22%)||41 (2%)|
|20 ( 6 7%)||12(40%)||5 (17%)||31 (0%)|
Other adverse events which were considered to be possibly, probably, or definitely related to Luxiq (betamethasone valerate foam) occurred in 1 patient each; these were paresthesia, pruritus, acne, alopecia, and conjunctivitis.
The following additional local adverse reactions have been reported with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximately decreasing order of occurrence: irritation; dryness; folliculitis; acneiform eruptions; hypopigmentation; perioral dermatitis; allergic contact dermatitis; secondary infection; skin atrophy; striae; and miliaria.
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients.
Read the entire FDA prescribing information for Luxiq (Betamethasone Valerate Foam)
Additional Luxiq Information
Luxiq - User Reviews
Luxiq User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.